Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mini-PCNL using the new Cyber Ho with Magneto technology versus thulium fiber laser: are there any differences?

World journal of urology·2026

Same author

Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-Aged Men - Data from the PROBASE Trial.

European urology·2026

Same author

Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.

Nature reviews. Urology·2026

Same author

Quality Assessment of Discarded Human Kidneys Using Normothermic Perfusion.

Transplantation direct·2026

Same author

Predictors of Prolonged Time to Ambulation After Radical Prostatectomy in a 23-hour Ambulatory Surgery Center.

JU open plus·2026

Same author

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Active surveillance for prostate cancer.

Javier Romero-Otero¹, Borja García-Gómez¹, José M Duarte-Ojeda¹

¹Urology Department, 12 de Octubre University Hospital, Madrid, Spain.

International Journal of Urology : Official Journal of the Japanese Urological Association

|December 2, 2015

Summary

Active surveillance for low-risk prostate cancer can reduce overtreatment without compromising survival. This strategy offers an option for patients to avoid immediate treatment side-effects, though criteria are not yet standardized.

Keywords:

active surveillance biological markers biopsy magnetic resonance imaging prostatic neoplasms

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Mar 29, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

Area of Science:

Urology
Oncology

Background:

Distinguishes between watchful waiting and active surveillance for prostate cancer.
Watchful waiting involves non-curative therapy upon symptomatic progression.
Active surveillance involves curative treatment upon disease progression signs.

Purpose of the Study:

Review the role of active surveillance in managing low-risk prostate cancer.
Evaluate the benefits and drawbacks of active surveillance.

Main Methods:

Systematic literature review using PubMed.
Search terms included: active surveillance, prostate cancer, watchful waiting, conservative management.
Included studies with detailed patient characteristics, inclusion criteria, and follow-up protocols.

Main Results:

Active surveillance may decrease overtreatment in low-risk prostate cancer.
Cancer-specific survival at 10 years is not compromised by active surveillance.
Active surveillance is a viable option for patients seeking to avoid immediate treatment side effects.

Conclusions:

Active surveillance is a suitable option for select low-risk prostate cancer patients.
Standardization of inclusion criteria and monitoring methods for active surveillance is needed.